Cargando…
Gene-Edited Interleukin CAR-T Cells Therapy in the Treatment of Malignancies: Present and Future
In recent years, chimeric antigen receptor T cells (CAR-T cells) have been faced with the problems of weak proliferation and poor persistence in the treatment of some malignancies. Researchers have been trying to perfect the function of CAR-T by genetically modifying its structure. In addition to th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353254/ https://www.ncbi.nlm.nih.gov/pubmed/34386015 http://dx.doi.org/10.3389/fimmu.2021.718686 |